↓ Skip to main content

Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway

Overview of attention for article published in Molecular Cancer, January 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway
Published in
Molecular Cancer, January 2013
DOI 10.1186/1476-4598-12-144
Pubmed ID
Authors

Leticia Oliveira-Ferrer, Jasmin Wellbrock, Udo Bartsch, Eva Maria Murga Penas, Jessica Hauschild, Marianne Klokow, Carsten Bokemeyer, Walter Fiedler, Gunter Schuch

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 8 29%
Student > Bachelor 4 14%
Student > Master 3 11%
Professor 2 7%
Researcher 2 7%
Other 3 11%
Unknown 6 21%
Readers by discipline Count As %
Medicine and Dentistry 9 32%
Engineering 4 14%
Agricultural and Biological Sciences 4 14%
Biochemistry, Genetics and Molecular Biology 3 11%
Immunology and Microbiology 1 4%
Other 1 4%
Unknown 6 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2015.
All research outputs
#2,500,328
of 9,380,044 outputs
Outputs from Molecular Cancer
#135
of 854 outputs
Outputs of similar age
#88,866
of 255,458 outputs
Outputs of similar age from Molecular Cancer
#5
of 17 outputs
Altmetric has tracked 9,380,044 research outputs across all sources so far. This one has received more attention than most of these and is in the 59th percentile.
So far Altmetric has tracked 854 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,458 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.